Daniel Wintner Goodman

TNXP

Daniel Wintner Goodman serves as Director at Tonix Pharmaceuticals Holding Corp. (TNXP). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$5.6K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$5.6K

Companies Traded

TNXP

Active Period

May 2021

1 total trades

Most Recent

Buy TNXP

May 26, 2021 · $5.6K

Daniel Wintner Goodman's Insider Trading at Tonix Pharmaceuticals Holding Corp. (TNXP)

Buys

1 · $5.6K

Sells

0 · $0.00

Total Shares Bought

5,000

Total Shares Sold

TNXP Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 26, 2021	Buy	5,000	$1.12	$5.6K	5,001

Related Insiders

LEDERMAN SETH

director, officer: Chief Executive Officer

TNXPBuy · Jun 9, 2026

Richard Newcomb Stillwell

director

TNXPBuy · Jun 9, 2026

Carolyn E. Taylor

Director

TNXPBuy · Aug 21, 2025

James Treco

Director

TNXPBuy · Aug 20, 2025

Explore More Insider Trading Data

TNXP Insider Trading Activity

View all insider trades at Tonix Pharmaceuticals Holding Corp.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity